Emerging Treatment Options in Inflammatory Bowel Disease
In Collaboration With
Original Article Reference
This SciPod is a shortened and simplified summary of ‘Emerging Treatment Options in Inflammatory Bowel Disease’, published by Karger Publishers https://doi.org/10.1159/000507782
The complete original works are available at www.karger.com
Share Episode
About this episode
Inflammatory bowel disease (IBD) is a group of gastrointestinal conditions affecting almost 7 million people globally, and this incidence is rising. While treatments have improved over the last century, many patients do not respond sufficiently, especially those with moderate to severe levels of the disease. Novel drugs that restrain the immune system and reduce inflammation are being developed with the hope of improving patient outcomes. Dr Benjamin Misselwitz at Island Hospital of Bern and Bern University and his colleagues have conducted a comprehensive review of the emerging therapies and make recommendations for improving treatment for a wider range of patients.
This work is licensed under a Creative Commons Attribution 4.0 International License. 
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
Related episodes
Prof. Debra Zoran | After the Storm: Protecting Companion Animals in Crisis
When disaster strikes, the images that dominate news coverage are almost always human centered. We see flooded neighborhoods, collapsed buildings, families waiting in shelters, and exhausted first responders. Yet woven into nearly every one of those scenes is another presence, often trembling at the end of a leash or peering out from a carrier. Companion animals are not an afterthought in modern life. They are family members, sources of emotional stability, and in some cases essential partners such as service dogs. As natural and human-made disasters grow in frequency and severity, the question of how to protect people inevitably includes the question of how to protect their animals.
Dr. Jeddah Marie Vasquez | Blending Biology and Engineering to Repair Damaged Nerves
When a peripheral nerve is badly damaged due to injury, the consequences can be life-changing. Hands that no longer feel heat or cold, muscles that will not respond to the brain’s commands, and pain that lingers for years are all common outcomes. Surgeons can sometimes stitch nerves back together, but when there is a section of nerve missing entirely, repair becomes far more complex. For decades, researchers have been trying to build better bridges for injured nerve axons to cross. A new interdisciplinary research effort led by Dr. Jeddah Marie Vasquez and Dr. Vijay Kumar Kuna of Research Institutes of Sweden, and their collaborators from Umeå University (Associate Professor Paul Kingham) and University College London (Professor James Phillips), bring together polymer chemistry, materials science, and cell biology to rethink what such a bridge could be made of – and how it might one day be tailored to individual patients.
Dr. Huda Makhluf | The Long Shadow: The Science Behind Long COVID
Four years after the first lockdowns and daily case counts faded from headlines, COVID 19 continues to shape lives in quieter but deeply disruptive ways. For millions of people around the world, the virus did not simply end with a negative test. Instead, it left behind a complex and often invisible condition known as long COVID. This lingering illness challenges how medicine understands recovery, chronic disease, and the long reach of viral infections. In a comprehensive review, Dr. Huda Makhluf of the National University in San Diego, and her colleagues, synthesize what scientists currently know about long COVID and what remains frustratingly uncertain.
Prof. Dr. Christopher Gerner | Ulcerative Colitis and the Hidden Logic of Chronic Disease
Ulcerative colitis, often called UC, is a chronic inflammatory disease of the large intestine that is becoming more common across the world, including among teenagers and young adults. For many patients it begins with subtle warning signs such as abdominal discomfort, diarrhea, fatigue, or traces of blood in the stool. Over time these symptoms can escalate into painful and frightening flare-ups that disrupt education, careers, family life, and emotional well-being. Although modern medicine has become remarkably effective at calming these acute disease episodes, UC remains stubbornly persistent. In most patients the disease returns after periods of apparent recovery, sometimes without any obvious external trigger.